English

English

LABORATORIOS SAVAL

Select Your Country

Products Finder

RIVOXA 15 mg y 20 mg

Platelet Aggregation Inhibitor

Active ingredients

Presentations

Rivoxa 15 mg: Package with 30 coated tablets
Rivoxa 20 mg: Package with 30 coated tablets

Bioequivalent: This product has demonstrated its therapeutic equivalence

Disponible en:

Composition

Each Rivoxa film-coated tablet contains:
Rivaroxaban 15 or 20 mg
Excipients: q.s.

Indications

Prevention of cerebrovascular accident and systemic embolism in adult patients with nonvalvular atrial fibrillation, with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, previous cerebrovascular accident or transient ischemic attack.

Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrences of DVT and PE in adults.